SCHEMBL8832241

SCHEMBL8832241

COC(=O)c1cccc2nc3c4ccccc4n(C)c3nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.53
▸ KDM4E B2RXH2 3/20 0.53
▸ GAA P10253 2/20 0.53
▸ ATM Q13315 1/20 0.53
▸ GABRP O00591 3/20 0.47
▸ GABRD O14764 3/20 0.47
▸ GABRA1 P14867 3/20 0.47
▸ GABRB1 P18505 3/20 0.47
▸ GABRG2 P18507 3/20 0.47
▸ GABRB3 P28472 3/20 0.47
▸ GABRA5 P31644 3/20 0.47
▸ GABRA3 P34903 3/20 0.47
▸ GABRA2 P47869 3/20 0.47
▸ GABRB2 P47870 3/20 0.47
▸ GABRA4 P48169 3/20 0.47
▸ GABRE P78334 3/20 0.47
▸ GABRA6 Q16445 3/20 0.47
▸ GABRG1 Q8N1C3 3/20 0.47
▸ GABRG3 Q99928 3/20 0.47
▸ GABRQ Q9UN88 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8832095 0.96 KMT2A (0.52) KMT2AKDM4EGAAATMGABRP
SCHEMBL71209 0.81 KDM4E (0.74) KMT2AKDM4EGAAATMLMNA
SCHEMBL8831926 0.80 KMT2A (0.58) KMT2AKDM4EGAAATML3MBTL1
SCHEMBL13653391 0.79 KMT2A (0.68) KMT2AKDM4EGAAATMLMNA
SCHEMBL24272528 0.75 MAPT (0.56) KMT2AKDM4EGAAGABRPGABRD
SCHEMBL3725674 0.75 KMT2A (0.67) KMT2AKDM4EGAAATMLMNA
SCHEMBL30149921 0.75 KMT2A (0.67) KMT2AKDM4EGAAATMLMNA
SCHEMBL8832023 0.75 L3MBTL1 (0.52) KMT2AKDM4EGAAATML3MBTL1
SCHEMBL16621922 0.74 MEN1 (0.68) KMT2AKDM4EGAAATML3MBTL1
SCHEMBL8479819 0.74 KMT2A (0.52) KMT2AKDM4EGABRPGABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597921-A ANTITUMOR AGENTS, TREATMENT OF LEUKEMIA TAISHO PHARMACEUTICAL CO., LTD. (JP) 1997-01-28 — — US disclosed
EP-0695754-A1 INDOLO 2,3-b]QUINOXALINE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1996-02-07 — — EP disclosed
Send feedback